Allele specific silencing therapy for the Dynamin 2-linked Dominant Centronuclear Myopathy - Archive ouverte HAL
Communication Dans Un Congrès Année : 2022

Allele specific silencing therapy for the Dynamin 2-linked Dominant Centronuclear Myopathy

Fichier non déposé

Dates et versions

hal-03920014 , version 1 (03-01-2023)

Identifiants

  • HAL Id : hal-03920014 , version 1

Citer

Delphine Trochet. Allele specific silencing therapy for the Dynamin 2-linked Dominant Centronuclear Myopathy. 17th International Congress on Neuromuscular Diseases, Jul 2022, Bruxels, Belgium. ⟨hal-03920014⟩
7 Consultations
0 Téléchargements

Partager

More